All these data together with the most recent findings on the efficacy of nitric oxide-targeted therapy in estrogen receptor-positive breast cancer cells [280] suggest that the entire NO pathway could play a key role in breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.